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Long-term multilineage reconstitution of le-
thally irradiated mouse bone marrow has been 
used as a gold standard to define the function-
ality of hematopoietic stem cells (HSCs). Based 
on this, HSCs have been studied extensively, 
yielding great contributions to the field of stem 
cell biology. The development of strategies for 
prospective isolation of HSCs has made in vivo 
clonal analysis of HSCs possible over the last 
decade. Analyses of individual purified HSCs 
or limiting doses of whole bone marrow trans-
planted into irradiated animals have revealed 
marked functional heterogeneity in HSCs with 
regard to repopulating activity, self-renewal 
activity, and in vitro colony-forming activity 
(Abkowitz et al., 2000; Müller-Sieburg et al., 
2002, 2004; Uchida et al., 2003; Takano et al., 
2004; Ema et al., 2005, 2006; Sieburg et al., 2006; 
Dykstra  et  al.,  2007).  Different  patterns  in 
lineage reconstitution by individual HSCs have 
also been observed (Uchida et al., 2003; Müller-
Sieburg  et  al.,  2004;  Sieburg  et  al.,  2006; 
Dykstra et al., 2007). Of interest is that the 
donor-derived myeloid/lymphoid ratio in re-
constituted mice reportedly indicates the degree 
of self-renewal potential in transplanted HSCs 
(Müller-Sieburg et al., 2004; Dykstra et al., 2007). 
If a variety of HSCs exist, HSCs may exhibit 
and  define  hierarchical  organization  within 
the most primitive hematopoietic compart-
ment. Alternatively, heterogeneity of HSCs 
may be generated during development of the 
hematopoietic system and remain fixed there-
after. To further address questions of func-
tional diversity and hierarchy in HSCs, HSC 
subsets with distinct properties must first be 
isolated prospectively.
CD34/low c-Kit+Sca-1+Lin (CD34KSL) 
cells in mouse bone marrow are highly en-
riched in adult HSCs (Osawa et al., 1996; Sudo 
et  al.,  2000;  Matsubara  et  al.,  2005;  Morita   
et al., 2006). To identify candidate cell-surface 
markers that could prospectively identify func-
tionally distinct HSCs, we screened a large 
number of antibodies and identified those with 
heterogeneous staining patterns on CD34KSL 
cells. These candidates were then tested for func-
tional differences in vivo. In this way, we found 
that expression of CD150 (Kiel et al., 2005) 
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Hematopoietic stem cells (HSCs) have been extensively characterized based on functional 
definitions determined by experimental transplantation into lethally irradiated mice. In 
mice, HSCs are heterogeneous with regard to self-renewal potential, in vitro colony-
forming activity, and in vivo behavior. We attempted prospective isolation of HSC subsets 
with distinct properties among CD34/low c-Kit+Sca-1+Lin (CD34KSL) cells. CD34KSL 
cells were divided, based on CD150 expression, into three fractions: CD150high, CD150med, 
and CD150neg cells. Compared with the other two fractions, CD150high cells were signifi-
cantly enriched in HSCs, with great self-renewal potential. In vitro colony assays revealed 
that decreased expression of CD150 was associated with reduced erythroblast/megakaryo-
cyte differentiation potential. All three fractions were regenerated only from CD150high 
cells in recipient mice. Using single-cell transplantation studies, we found that a fraction 
of CD150high cells displayed latent and barely detectable myeloid engraftment in primary-
recipient mice but progressive and multilineage reconstitution in secondary-recipient mice. 
These findings highlight the complexity and hierarchy of reconstitution capability, even 
among HSCs in the most primitive compartment.
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lymphoid-primed multipotent progenitors (LMPPs; Adolfsson 
et al., 2001, 2005). These markers, as well as CD11a (LFA1), 
CD62L (L-selectin), and CD138 (Syndecan1), can be used 
for better discrimination of CD34 from CD34+ cells within 
the KSL population. Whether N-cadherin is expressed on 
HSCs remains somewhat controversial (Zhang et al., 2003; 
Kiel et al., 2007, 2008; Haug et al., 2008). In our analysis, 
CD34KSL cells did not express N-cadherin, as additionally 
demonstrated in Fig. S1.
On  the  other  hand,  22  markers  were  expressed  on 
CD34KSL cells, as depicted in Fig. S2. Although most such 
markers were expressed on both CD34 and CD34+KSL 
cells, expression of CD27, CD201, and c-Mpl seemed down-
regulated on some CD34+KSL cells. This is consistent with ear-
lier reports in which CD201 and c-Mpl were used as positive 
markers for HSC purification (Balazs et al., 2006; Yoshihara 
et al., 2007). Only 15 markers showed variable expression on 
CD34KSL  cells.  We  were  particularly  interested  in  this 
group of markers because their use permitted us to test frac-
tions of CD34KSL cells to determine whether they might 
represent functionally distinct subsets of HSCs. These candi-
dates were AA4.1, CD1d, CD11b, CD18, CD31, CD38, 
CD49b, CD51, CD61, CD86, CD103, CD147, CD150, 
FcR, and Tie2 (Fig. 1).
Based on expression of these antigens, CD34KSL cells 
were sorted into positive and negative fractions by flow cy-
tometry. In the case of CD38, CD34KSL cells were separated 
into CD38high and CD38med fractions, which amounted to 
22.4 ± 3.8% and 56.1 ± 5% of CD34KSL cells, respectively 
(n = 5; mean ± SD); the CD38neg fraction was barely detect-
able. In the case of CD150, CD34KSL cells were separated 
into CD150high, CD150med, and CD150neg fractions (Fig. 1). 
These represented 26 ± 5.6%, 24 ± 2.9%, and 14.6 ± 3.6% of 
CD34KSL cells, respectively (n = 8; mean ± SD); CD150 
expression levels varied widely among CD34KSL cells.
We  next  used  transplantation  to  compare  the  in  vivo 
function of fractions of CD34KSL cells. Each of a group of 
lethally irradiated mice received 10 cells from these individual 
fractions along with 2 × 105 competitor cells. Recipient mice 
were analyzed between 16 and 20 wk after transplantation. 
As shown in Fig. 2, long-term (16 wk or more) repopulating 
activity was detected in both the positive and negative frac-
tions in all cases, suggesting that none of these markers is par-
ticularly useful for excluding non-LTRCs from CD34KSL 
cells. However, we found significant differences in the per-
centage of chimerism among fractions separated on the basis 
of expression of CD38, CD147, CD150, and Tie2 (Fig. 2).
We observed particularly interesting reconstitution kinetics 
patterns in the cases of CD150 and CD38. CD150highCD34 
KSL cells exhibited low levels of reconstitution in the early 
phase after transplantation, but reconstitution levels gradually in-
creased thereafter (15 out of 19; Fig. 3). CD150medCD34KSL 
cells exhibited relatively high levels of reconstitution in the 
early phase, and these levels were maintained (11 out of 19). 
CD150negCD34KSL cells exhibited low levels of reconstitu-
tion in the early phase without change thereafter (9 out of 14), 
could be used to enrich for long-term repopulating cells 
(LTRCs)  with  distinct  reconstitution  kinetics  patterns. 
CD34KSL cells were subdivided into CD150high, CD150med, 
and CD150neg fractions, and the functions of these cells were 
compared at the clonal level using single-cell transplantation 
and cultures.
While performing this study, we noticed the existence of 
a very rare type of LTRCs. These cells were named “latent 
HSCs” and were operationally defined as cells that exhibited 
significant engraftment only after 12 wk or more in the pri-
mary recipient yet showed multilineage reconstitution in the 
secondary recipient. Given that these cells could fully recon-
stitute the secondary recipients, they are assumed to have 
high reconstitution potential. However, they do not satisfy 
(at the level of primary transplantation) some of the criteria 
that currently define HSCs.
Our results indicate that differences in reconstitution ac-
tivity are caused by intrinsic differences among cells and that 
classes of HSCs with distinct in vivo behavior can be pro-
spectively isolated. We also report the discovery of a very 
slowly engrafting, myeloid-biased HSC whose full potential 
can be seen only after secondary transplantation. The exis-
tence of latent HSCs requires reconsideration of the concept 
of HSCs and leads us to propose a revision of the current 
criteria for HSCs.
RESULTS
Fractions in CD34KSL cells
As in previous studies (Abkowitz et al., 2000; Müller-Sieburg 
et al., 2002, 2004; Uchida et al., 2003; Sieburg et al., 2006; 
Dykstra et al., 2007), our single-cell transplantation experiments 
yielded data showing that CD34KSL cells display hetero-
geneous reconstitution patterns in primary- and secondary-
recipient mice (Ema et al., 2005). For instance, there are HSCs 
that sequentially reconstitute myeloid, B lymphoid, and   
T lymphoid lineages in primary-recipient mice, followed by 
multilineage reconstitution that is maintained in secondary- 
recipient mice; HSCs that predominantly reconstitute myeloid 
lineage in primary-recipient mice, followed by greater levels of 
multilineage reconstitution in secondary-recipient mice; and 
HSCs  that  predominantly  reconstitute  lymphoid  lineage  in 
primary-recipient mice, followed by markedly reduced levels 
of  reconstitution  in  secondary-recipient  mice.  To  achieve 
greater purification of HSCs, and to identify cell-surface mark-
ers that distinguish HSCs with heterogeneous reconstitution 
behaviors, CD34KSL cells were costained with a compre-
hensive list of additional antibodies (Table S1) and analyzed by 
flow cytometry (Fig. 1; and Figs. S1 and S2).
In this study, 118 cell-surface markers listed in Table S1 
were examined. Among them, 81 markers appeared not to 
be expressed on CD34KSL cells. Most of these were not   
expressed on CD34+KSL cells either, with some notable ex-
ceptions, as shown in Fig. S1. Markers with heterogeneous 
expression in CD34+KSL cells include CD48 and CD244, 
members of the Slam family recognized as negative markers 
for HSCs (Kiel et al., 2005), and CD135, used to isolate JEM VOL. 207, June 7, 2010 
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The similarity in reconstitution pattern between 
CD38high and CD150high CD34KSL cells prompted 
us to examine simultaneously the expression of these 
two markers on CD34KSL cells. As shown in 
Fig. S3, most CD38highCD34KSL cells expressed 
CD150 strongly. These data let us focus on CD150 
as a marker that might permit identification of dis-
tinct HSC subsets.
Identification of distinct LTRCs
To compare the frequencies and functional prop-
erties of LTRCs within CD150high, CD150med, 
and CD150negCD34KSL cells, single-cell trans-
plantation was performed. Cells were individu-
ally transplanted into each of a total of 40 lethally 
irradiated mice together with 2 × 105 competitor 
cells in two independent experiments. 6–7 mo 
later, secondary transplantation was performed by 
injecting 5 × 106 bone marrow cells from recon-
stituted recipient mice into three to five lethally 
irradiated mice.
During these experiments, we made an impor-
tant observation. Some LTRCs showed very low 
levels of myeloid reconstitution in primary-recipient 
mice  but  exhibited  much  higher  reconstitution 
levels in secondary-recipient mice. In this study, therefore, 
we considered reconstitution to have been achieved when 
the percentage of donor chimerism was 0.3% or more at one 
time point or more after transplantation, regardless of which 
lineage was reconstituted.
Results  of  primary  and  secondary  transplantation  with 
single cells are shown in Fig. 4. In the three 40-mouse cohorts 
that were primary recipients of CD150high, CD150med, and 
CD150negCD34KSL cells, LTRC activity was detected in 
16, 13, and 13 mice, respectively. The similar rates of recon-
stitution suggest that LTRCs are equally present among 
CD150high, CD150med, and CD150negCD34KSL cells.
Results  of  secondary  transplantation  differed  remarkably, 
however.  After  secondary  transplantation,  LTRCs  were  de-
tected in all of the recipient mice transplanted from primary- 
recipient  mice  that  had  initially  received  CD150highCD34 
KSL cells (Fig. 4 A). In most recipient mice, hematopoiesis was 
sustained 5 mo after secondary transplantation. Unfortunately, 
with the exception of one case in which the level of recon-
stitution gradually increased. Lineage compositions in re-
constituted mice significantly differed between recipients 
of CD150high and recipients of CD150negCD34KSL cells 
(P < 0.0001 by the t test; Fig. 3). When CD150highCD34KSL 
cells were transplanted, the myeloid lineage was more re-
constituted than the lymphoid lineage. In contrast, when 
CD150negCD34KSL cells were transplanted, the lymphoid 
lineage was more reconstituted than the myeloid lineage. 
CD150medCD34KSL cells gave rise to a seemingly inter-
mediate pattern between those obtained using CD150high cells 
and those obtained using CD150neg cells. In addition, the 
percentages of chimerism 16 wk after transplantation with 
CD150medCD34KSL cells were significantly greater than 
those with CD150high or CD150negCD34KSL cells (Fig. 2). 
CD38high and CD38medCD34KSL cells exhibited reconsti-
tution kinetics similar to CD150high and CD150negCD34KSL 
cells, respectively (unpublished data).
Figure 1.  Markers with heterogeneous expression in 
CD34KSL cells. KSL cells were stained with FITC-conju-
gated anti-CD34 antibody and additional PE-conjugated 
antibodies as shown. Shown are flow cytometric profiles for 
the markers that had heterogeneous expression within 
CD34KSL cells (percentages are shown). Marker-positive or 
-negative cells were separated by using the sorting gates 
(shown as squares). In the case of CD150, CD34KSL cells 
were separated into CD150high, CD150med, and CD150neg frac-
tions. In the case of CD38, CD34KSL cells were separated 
into CD38high and CD38med fractions. The data represent four 
to eight independent experiments.1176 Heterogeneity and hierarchy of HSCs | Morita et al.
mary  and  secondary  transplantation 
in 10 out of 13 cases initiated with   
single  CD150highCD34KSL  cells. 
When CD150medCD34KSL cells were   
transplanted, this progressive increase oc-
curred in only 1 out of 13 cases, and when 
CD150negCD34KSL cells were trans-
planted, no such instance was observed 
out of 12 cases. From these data, we 
concluded  that  CD150highCD34KSL 
cells are greatly enriched in highly self-
renewing LTRCs.
Noteworthy is that a latent and a   
myeloid-limited type of LTRCs existed 
among CD150highCD34KSL cells. 
Cells of the latent type represented 1 
out of every 10 CD150highCD34KSL 
cells (approximately one in a million 
total bone marrow cells) and produced 
virtually undetectable levels of blood 
cells for several months after transplan-
tation. Beginning at 12 wk or later, 
these  LTRCs  effected  a  low  level 
of myeloid reconstitution (Fig. 4 A, 
cases #3, #5, #6, and #16). How-
ever,  these  cells  showed  progressive 
and  robust  repopulating  activity  in 
secondary-recipient mice. Cells of the 
myeloid-limited  type  represented  1 
out of 20 CD150highCD34KSL cells 
and exhibited a low level of myeloid reconstitution without 
lymphoid reconstitution during primary and secondary trans-
plantation (Fig. 4 A, cases #7 and #15).
Figs. S4–S6 show reconstitution kinetics in individual 
secondary-recipient mice of bone marrow cells reconsti-
tuted  with  single  CD150high,  CD150med,  and  CD150neg 
CD34KSL cells. When high levels of reconstitution took 
place in primary-recipient mice, high levels of reconstitu-
tion were achieved in all secondary-recipient mice (e.g., 
cases #1 and #2; Fig. S4). As previously reported (Müller-
Sieburg et al., 2002; Dykstra et al., 2007), reconstitution 
patterns were very similar among secondary-recipient mice 
in each group. However, in the case of latent LTRCs, various 
levels of reconstitution were observed for secondary-recipient 
three primary-recipient mice in this cohort could not be used as 
donors for secondary transplantation because they died early.
Among the primary recipients of CD150med and CD150neg 
CD34KSL cells, one and two mice died, respectively. 
LTRCs were detected in 4 out of 13 and in 2 out of 12 
cohorts of secondary-recipient mice whose donors had ini-
tially received CD150med and CD150negCD34KSL cells, 
respectively. Consistent with data from 10-cell transplanta-
tion experiments (Fig. 3), CD150highCD34KSL cells pre-
dominantly  reconstituted  the  myeloid  lineage,  whereas 
CD150negCD34KSL cells predominantly reconstituted the 
lymphoid lineage (Fig. 4).
With respect to in vivo reconstitution kinetics, percent-
ages of chimerism progressively increased throughout pri-
Figure 2.  Long-term reconstitution by 
fractions of CD34KSL cells. CD34KSL 
cells were subdivided into fractions positive 
and negative for additional markers. 10 cells 
from each fraction were transplanted into 
each member of a group of lethally irradiated 
mice along with 2 × 105 competitor cells. 
Recipient mice were analyzed 4–5 mo after 
transplantation. Chimerism levels for all indi-
viduals in each group of mice are shown. 
Horizontal lines represent means.JEM VOL. 207, June 7, 2010 
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these data suggest a continuum of expres-
sion  of  CD150  among  CD34KSL  cells, 
where CD150 expression is tightly associ-
ated  with  repopulation  kinetics  and  with 
self-renewal potential.
Identification of balanced LTRCs
On  single-cell  transplantation,  CD150med 
CD34KSL cells did not show any unique 
properties  as  compared  with  CD150high  or  CD150neg 
CD34KSL cells. Also, the percentage of balanced LTRCs, 
like  cells, in all single-cell transplants was less than that in 
previous studies (Ema et al., 2005; Dykstra et al., 2007). In 
the single-cell experiments described in the previous sec-
tion, we set a rather narrow gate for the CD150medCD34KSL 
cells to see the difference more clearly, as in Fig. 1 (bot-
tom). Although a relatively large number of cells lay be-
tween the CD150med and CD150high CD34KSL fractions, 
these  cells  were  not  sorted.  We  assumed  that  balanced 
LTRCs are mostly in this population. To address the effects 
of gating, we performed two independent single-cell trans-
plantation experiments. In these experiments, gates were set 
to  sort  CD34KSL  cells  into  four  fractions:  CD150high, 
CD150int, CD150low, and CD150neg, as shown in Fig. S8 A. 
LTRCs were detected in 11, 12, 10, and 9 recipient mice of 
CD150high, CD150int, CD150low, and CD150negCD34KSL 
cells, respectively. Results from the CD150high and CD150neg 
transplants were nearly identical to the initial single-cell 
mice in each group (e.g., cases #6 and #16; Fig. S4). Further-
more, reconstitution patterns differed remarkably among re-
cipient mice. Although only myeloid-lineage reconstitution 
was detected in primary-recipient mice of latent LTRCs,   
B and T lymphoid lineages became readily detectable in 
most secondary-recipient mice.
Dykstra et al. (2007) recently proposed that four types of 
LTRCs exist based on their observations in single-cell trans-
plantation. According to their classification,  cells show a 
myeloid/lymphoid contribution ratio of >2:1,  cells show 
a balanced ratio between 1:4 and 2:1,  cells show a my-
eloid/lymphoid contribution ratio of <1:4, and  cells show 
a ratio of <1:4, with < 1% myeloid reconstitution. As shown 
in Fig. S7, 75% of CD150highCD34KSL LTRCs qualified 
as  cells and the remaining cells qualified as  cells. On the 
other hand, 100% of CD150negCD34KSL LTRCs quali-
fied as  or  cells. Among CD150medCD34KSL LTRCs, 
15% were assigned to each of the , , and  cell categories, 
with the remaining cells assigned as  cells. Collectively, 
Figure 3.  Reconstitution kinetics with CD150high, 
CD150med, and CD150neg CD34KSL cells. Each of 
a group of lethally irradiated mice received 10 CD150high 
cells, 10 CD150med cells, or 10 CD150negCD34KSL 
cells. (left) The change in the percentage of chime-
rism over time. Blood of recipient mice was analyzed 
2, 3, 4, and 5 mo after transplantation. Each line 
shows a change in the percentage of chimerism from 
one recipient mouse. (right) The relative myeloid,  
B lymphoid, and T lymphoid lineage contributions in 
reconstituted donor-derived blood cells of individual 
recipient mice 4 mo after transplantation. Myeloid 
lineage represents 53.7 ± 27.2% (n = 19), 22 ± 21.8% 
(n = 19), and 13 ± 21.7% (n = 14; mean ± SD) after 
transplantation with CD150high, CD150med, and 
CD150negCD34KSL cells, respectively. B lymphoid 
lineage represents 38.2 ± 21.5% (n = 19), 56.2 ± 17.9% 
(n = 19), and 60.7 ± 21.5% (n = 14; mean ± SD)  
after transplantation with CD150high, CD150med, and 
CD150negCD34KSL cells, respectively. T lymphoid 
lineage represents 8 ± 8.4% (n = 19), 21.8 ± 9.4%  
(n = 19), and 26.3 ± 19.4% (n = 14; mean ± SD) after 
transplantation with CD150high, CD150med, and 
CD150negCD34KSL cells, respectively. The proportion 
of myeloid lineage reconstitution by CD150high 
CD34KSL cells was significantly greater than that of 
CD150negCD34KSL cells (P < 0.0001).1178 Heterogeneity and hierarchy of HSCs | Morita et al.
LTRCs were present just beneath the CD150highCD34KSL 
cells. These data provide further evidence that functionally 
distinct LTRCs can be identified according to their levels of 
CD150 expression.
transplantation experiments (Fig. S7 B). On the other hand, 
CD150intCD34KSL LTRCs exhibited high levels of chi-
merism (Fig. S8 B), and the majority (7 out of 12) were 
classified as  cells, revealing that large numbers of balanced 
Figure 4.  Single-cell transplantation. (A–C) Single CD150highCD34KSL (A), CD150medCD34KSL (B), and CD150negCD34KSL cells (C) were trans-
planted into 40 lethally irradiated mice together with 2 × 105 competitor cells. Blood of recipient mice was periodically analyzed 1, 2, 3, 4, and 5 mo after 
transplantation. Secondary transplantation was performed using 5 × 106 reconstituted bone marrow cells of recipient mice. Blood of secondary-recipient 
mice was periodically analyzed 1, 2, 3, 4, and 5 mo after transplantation. Data from secondary transplantation show the mean percentage of chimerism  
(n = 3–5). The five sequential bars for each recipient mouse indicate the percentage of chimerism 1, 2, 3, 4, and 5 mo after transplantation. *, mice that 
died before secondary transplantation.JEM VOL. 207, June 7, 2010 
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fied three distinct subsets of LTRCs with regard to repopulating 
activity, self-renewal potential, in vitro colony-forming acti-
vity, and in vivo kinetics after transplantation.
CD150highCD34KSL  cells  were  highly  enriched  in 
LTRCs, with greater self-renewal potential than cells in the 
other two subsets (Figs. 3 and 4). The repopulating activity in-
creased gradually from primary through secondary transplanta-
tion. Myeloid reconstitution significantly dominated lymphoid 
reconstitution. On average, 87.5% of CD150highCD34KSL 
cells formed colonies in vitro. More than half of the colonies 
included all nmEM elements. These data imply an association 
among high self-renewal potential, myeloid-biased reconstitu-
tion, and nmEM differentiation potential.
CD150negCD34KSL cells were highly enriched in LTRCs, 
with limited self-renewal potential (Figs. 3 and 4). The re-
populating activity decreased from primary through second-
ary transplantation. Lymphoid reconstitution significantly 
dominated myeloid reconstitution. Only limited myeloid 
reconstitution  was  observed  in  some  cases.  On  average, 
85% of CD150negCD34KSL cells formed colonies in vitro, 
and 73% of these colonies consisted of only neutrophil/
macrophage or macrophage elements. These data imply an 
association among low self-renewal potential, lymphoid-
biased reconstitution, and loss of erythroid and megakaryo-
cytic potential.
Kent et al. (2009) recently reported that HSCs with higher 
repopulating activity are enriched in the CD150+ subset of 
EPCR+CD48CD45+ bone marrow cells, whereas those in 
the CD150 subset have limited self-renewal activity. These 
data all support our hypothesis that CD150 expression levels 
can be used prospectively to separate distinct types of LTRCs.
In this study, we found latent LTRCs among CD150high 
CD34KSL cells that exhibited a very late onset of repopula-
tion (>4 mo after transplant) despite exposure to the “cytokine 
storm” presumed to rage in the early phase of reconstitution. 
Cells similar to LTRCs of the latent type have been described 
by some groups (Ortiz et al., 1999; Dykstra et al., 2007). The 
existence of such LTRCs challenges the current experimen-
tal definition of HSCs: multilineage reconstitution in primary 
Colony-forming ability in distinct LTRCs
Single-cell liquid cultures were performed to compare in vitro 
colony-forming abilities among CD150high, CD150med, and 
CD150negCD34KSL cells. Cells were individually cultured 
(48 cells from each fraction) for 14 d in the presence of stem 
cell factor, thrombopoietin, IL-3, and erythropoietin.
Frequencies of colony formation were similar among these 
fractions (Fig. 5). The colony types formed, however, differed 
markedly. On average, 60% of CD150highCD34KSL cells 
formed  neutrophil/macrophage/erythroblast/megakaryocyte 
(nmEM) colonies, whereas only 7% of CD150negCD34KSL 
cells did so. In contrast, 66% of CD150negCD34KSL cells 
formed  neutrophil/macrophage  colonies,  whereas  12%  of 
CD150highCD34KSL  cells  did  so.  CD150medCD34KSL 
cells  seemed  to  exhibit  activity  in  between  that  of  CD-
150high and CD150negCD34KSL cells. These results suggest 
that the loss of erythroblast/megakaryocyte differentiation   
potential is associated with loss of CD150 expression within 
CD34KSL cells.
Hierarchical order in distinct LTRCs
From transplantation data, we predicted that CD150high cells 
reside in the uppermost portion of the hematopoietic hierar-
chy. To assess this, we evaluated the reversibility of CD150 
expression. Three cohorts of three mice that had been reconsti-
tuted with 10 CD150high, CD150med, or CD150negCD34KSL 
cells were analyzed 8 mo after transplantation. Flow cyto-
metric analysis was performed on bone marrow cells from   
these mice to assess CD150 expression on reconstituted 
CD34KSL cells. To distinguish test donor-derived cells from 
competitor- and recipient-derived cells, only Ly5.1+Ly5.2 
cells were gated and analyzed. As shown in Fig. 6, test donor-
derived CD150highCD34KSL cells were detected in each of 
the three mice transplanted with CD150highCD34KSL cells. 
The CD150 expression pattern in the reconstituted CD34KSL 
cells mimicked that seen in freshly isolated CD34KSL cells. 
Very few CD150highCD34KSL cells were detected in one out 
of three mice transplanted with CD150medCD34KSL cells. 
Test donor-derived KSL cells were not detected in three mice 
transplanted  with  CD150negCD34KSL  cells  (unpublished 
data). These data support our hypothesis that CD150high cells 
rank highly among CD34KSL cells.
DISCUSSION
Single-cell culture and transplantation are powerful assays 
for  the  characterization  of  individual  HSCs  (Ema  et  al.,   
2000, 2005, 2006; Takano et al., 2004; Seita et al., 2007). 
Our experience with >2,000 single-cell transplantations of 
CD34KSL cells leads us to expect engraftment in 20–50% 
of recipients. Since establishment of this experimental system, 
we have been searching for markers useful to further enrich 
for HSCs. During the course of these studies, we have found, 
even  among  CD34KSL  cells,  extensive  heterogeneity  in   
reconstitution activity that could be identified only by clonal 
analysis. This study challenges received ideas on the prospec-
tive isolation and identification of HSC subsets. We identi-
Figure 5.  Colony formation by single cells. Single-cell cultures were 
performed using CD34KSL, CD150highCD34KSL, CD150medCD34KSL, 
and CD150negCD34KSL cells. 48 CD34KSL, CD150highCD34KSL, 
CD150medCD34KSL, and CD150negCD34KSL cells formed 44 ± 3, 42 ± 5, 
45 ± 3, and 41 ± 4 colonies, respectively (n = 3; mean ± SD). E, erythro-
blast; m, macrophage; M, megakaryocyte; n, neutrophil.1180 Heterogeneity and hierarchy of HSCs | Morita et al.
CD34KSL population. In addition, there may be 
other novel types of HSCs that were not detected by 
the current assay system. Given such heterogeneity 
even among the most primitive HSC compartment, 
the criteria for HSC identification must be rede-
fined. Considering the data presented in this paper, 
multilineage reconstitution in a secondary transplant 
recipient appears to be a useful baseline definition 
for conventional HSCs. This definition would prob-
ably  include  HSCs  and  define  myeloid-limited 
LTRCs. If this definition is applied, 11 CD150high, 
2 CD150med and 1 CD150negCD34KSL LTRCs in 
the initial single-cell transplantation experiments are 
considered  as  conventional  HSCs.  However,  this 
definition requires expensive and time-consuming 
experiments.  Therefore,  novel  assays  that  permit 
rapid  and  efficient  detection  of  all  sorts  of  HSCs 
need to be developed.
Of interest is how such HSCs with diverse re-
constitution capacity and kinetics are generated. We have 
shown that HSC dormancy occurs via hibernation (Yamazaki 
et al., 2006). Although latent HSCs appear to be found pri-
marily within CD150highCD34KSL cells, because they are 
so infrequent it is as yet unclear whether they differ from 
other HSCs in their expression of FOXO transcriptional 
factors, cell-cycle regulators, and other molecules assumed 
to be involved in hibernation. Alternatively, different niches 
may differently regulate HSC hibernation and responses to 
cytokines. Of particular interest will be to determine to what 
extent the latent HSCs found in this study are relevant to   
the recently reported infrequently cycling HSCs among 
CD150+CD34KSL cells (Wilson et al., 2008; Foudi et al., 
2009). Recent reports of cell-cycle regulation by TGF- in 
HSCs (Yamazaki et al., 2008; Challen et al., 2010) raise the 
possibility of its involvement in the unique behavior of la-
tent HSCs. Understanding the mechanism that controls the 
latent HSC cell cycle may contribute to exploration of the 
pathogenesis and treatment of some forms of leukemia in 
which quiescent leukemic stem cells may be highly resistant 
to current chemotherapy.
As the heterogeneity of HSCs with respect to their dif-
ferentiation potentials becomes better understood, hemato-
poietic differentiation pathways from HSCs to mature blood 
cells also become more complicated than previously thought 
(Adolfsson et al., 2005; Arinobu et al., 2007). In particular, 
early differentiation pathways remain poorly understood. 
Based on our data from this study, we propose a hierarchical 
recipients 12–16 wk after transplantation. Of importance is 
that, in addition to this late onset of engraftment, these cells 
do not always show multilineage reconstitution at a particu-
lar  point  after  transplantation.  Because  of  these  unique 
properties, these cells are not likely defined as HSCs by 
current experimental criteria. Furthermore, we have found 
mice in which engraftment was not observed until 8 mo af-
ter transplant. We have also experienced cases in which 
multilineage engraftment was confirmed only in the second-
ary recipients, with no engraftment at all in the primary re-
cipients (unpublished data).
In addition, we have found “myeloid-limited LTRCs” 
among CD150highCD34KSL cells. These cells exhibited 
low-level but continuous myeloid reconstitution for at least 
40 wk, with no detectable lymphoid differentiation poten-
tial. We speculate that they may be downstream of latent 
HSCs, because latent HSCs exhibit myeloid-predominant 
reconstitution  in  primary-recipient  mice  and  express  the 
same markers as those expressed by myeloid-limited LTRCs. 
CD150highCD34KSL cells also contain at least two other 
types of LTRCs. One exhibits balanced reconstitution dur-
ing primary and secondary transplantations (Fig. 4 A, cases 
#1 and #12). The other exhibits myeloid-predominant 
reconstitution, with high repopulating activity and with-
out delayed reconstitution, during primary and secondary 
transplantations (Fig. 4 A, cases #2, #8, and #10). The   
use of additional markers may permit distinction of these 
functionally distinct LTRCs from among the CD150high 
Figure 6.  Regeneration of CD150highCD34KSL cells  
after transplantation. (A) Three recipient mice reconstituted 
with 10 CD150high or CD150medCD34KSL cells were analyzed  
8 mo after transplantation. CD34 and CD150 expression by KSL 
bone marrow cells derived from CD150highCD34KSL or 
CD150medCD34KSL cells is shown (percentages are shown).  
(B) Reconstitution kinetics of recipient mice described in A.JEM VOL. 207, June 7, 2010 
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-CD127,  –Gr-1,  or  -TER119  antibodies,  each  antibody  was  excluded 
from the lineage marker cocktail. To prepare cells for sorting, low-density 
cells were depleted of lineage marker–positive cells using magnetic beads 
(Miltenyi Biotec).
Flow  cytometric  analysis  and  sorting  were  performed  on  a  MoFlo 
(Beckman Coulter) equipped with solid-state (488-nm) and HeNe (633-nm) 
lasers, or a FACSVantage SE (BD).
Transplantation. Competitive repopulation assays with 2 × 105 whole 
bone marrow cells from Ly5.1/Ly5.2-F1 mice were performed in B6-Ly5.2 
mice lethally irradiated with two doses of 4.75 Gy, delivered 4 h or more 
apart. 1 or 10 cells were transplanted per recipient mouse. Peripheral blood 
cells from the recipient mice were analyzed at 1, 2, 3, 4, and 5 mo after 
transplantation.  After  erythrocyte  lysis,  cells  were  stained  with  FITC- 
conjugated anti–Ly5.2, PE-Cy7–conjugated anti-B220, PE-conjugated anti-
CD4 and -CD8, APC-conjugated anti–Mac-1 and –Gr-1, and biotinylated 
anti-Ly5.1  antibodies.  The  biotinylated  antibody  was  developed  with 
streptavidin–Alexa Fluor 594. Before flow cytometric analysis, cells were 
suspended in PBS containing 1 µg/ml propidium iodide. Six-color flow 
cytometric analysis was performed using a FACSVantage SE equipped with 
argon (488-nm) and dye (599-nm) lasers. The percentage of chimerism was 
defined as follows: (percentage of Ly5.1+ test donor cells) × 100/(percentage 
of Ly5.1+ test donor cells + percentage of F1 competitor cells). If chimerism 
was 0.3% or more at any time point after transplantation, regardless of which 
lineage was reconstituted, mice were considered to be reconstituted with test 
donor cells.
Secondary  transplantation  was  performed  by  transferring  5  ×  106 
bone marrow cells from femurs and tibias of the primary-recipient mice 
into each of three to five lethally irradiated B6-Ly5.2 mice. Peripheral 
blood cells from the secondary-recipient mice were analyzed at 1, 2, 3, 4, 
and 5 mo after transplantation.
LTRCs were defined as cells that exhibited 0.3% or more chimerism 
16 wk or more after transplantation. Latent HSCs were defined as HSCs 
that began to exhibit 0.3% or more chimerism beginning at 12 wk or more 
after primary transplantation and exhibited multilineage reconstitution after 
secondary transplantation.
Single-cell colony assays. Cells were sorted clonally into 96-well plates 
containing 200 µl S-clone SF-O3 medium (Sanko Junyaku) supplemented 
with 10% fetal bovine serum, 1% bovine serum albumin, 10 ng/ml mouse stem 
cell factor, 10 ng/ml human thrombopoietin, 10 ng/ml mouse IL-3, 1 U/ml 
human erythropoietin (PeproTech), and 5 × 105 M -mercaptoethanol. 
After culture for 14 d, colonies were cytocentrifuged onto glass slides and 
stained with Hemacolor (Merck). Cells comprising colonies were identified 
by light microscopy using morphological criteria.
Online  supplemental  material. Fig. S1 shows flow cytometric pro-
files of the markers that were expressed by CD34+KSL cells but not by 
CD34KSL cells. Fig. S2 shows flow cytometric profiles of the markers 
that were expressed by CD34KSL cells. Fig. S3 shows coexpression of 
CD150 and CD38 in CD34KSL cells. Figs. S4–S6 show the percent-
age of chimerism of individual secondary-recipient mice. Fig. S7 shows 
the classification of LTRCs in CD150 subsets. Fig. S8 shows that the 
CD150intCD34KSL  fraction  is  enriched  in  balanced  LTRCs.  Fig.  S9 
shows the hierarchal organization model within the primitive HSC com-
partment. Fig. S10 shows the classification of LTRCs in secondary trans-
plantation. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091318/DC1.
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organization model in which CD150high cells with high self-
renewal potential give rise to CD150med cells with moderate 
self-renewal potential and, finally, to CD150neg cells with 
very limited self-renewal potential (Fig. S9).
When CD150high, CD150med, and CD150negCD34KSL 
LTRCs in secondary recipients were classified based on the 
schema in Dykstra et al. (2007), it was interesting to note 
that their classes shifted toward more lymphoid potential 
than in primary recipients (Fig. S10). The latent HSCs also 
exhibited varying reconstitution patterns among secondary 
recipients in the same groups. These data support our hierar-
chical organization model.
LMPPs have been shown to have B lymphoid, T lym-
phoid, and neutrophil/macrophage differentiation poten-
tials  without  erythroblast/megakaryocyte  differentiation 
potential (Adolfsson et al., 2005). In this study, we showed 
that CD150neg cells have very similar potential but greater 
repopulating activity. Thus, it seems likely that CD150neg 
cells give rise to LMPPs. Reduced expression of CD150   
is associated with reduction of self-renewal potential and 
loss of erythroblast/megakaryocyte differentiation potential, 
leading  to  neutrophil/macrophage  and  lymphoid-lineage 
specification. Although CD150 expression levels can be 
used to mark self-renewal potential and myeloid predomi-
nance, as yet we have no idea why HSCs with high self- 
renewal activity express high levels of CD150, nor do we 
know the function of CD150. Our data imply that self- 
renewal potential, biased differentiation manner, and reconsti-
tution kinetics are predetermined by an intrinsic program 
within HSCs. Future studies should clarify the physiological 
and pathological roles of these HSC subsets in the hemato-
poietic system.
MATERIALS AND METHODS
Mice. C57BL/6 mice congenic for the Ly5 locus (B6-Ly5.1 mice) were 
bred and maintained at Sankyo Labo Service. B6-Ly5.2 mice were pur-
chased from Japan SLC. All procedures were approved by the Animal Care 
and Use Committee, Institute of Medical Science, University of Tokyo.
Screening  of  antibodies.  Antibodies  used  for  screening  are  listed  in 
Table S1. Bone marrow cells were obtained from 8–10-wk-old B6-Ly5.1 
mice and were suspended in PBS. Low-density cells (<1.077 g/ml) were 
isolated  by  density  gradient  centrifugation  and  were  stained  with  each 
additional antibody for screening. For staining of FITC- or Alexa Fluor 
488–conjugated  additional  antibodies,  CD34KSL  cells  were  identified 
by  PE-conjugated  anti–Sca-1  (D7;  eBioscience),  PE-Cy7–conjugated 
anti–c-Kit  (2B8;  eBioscience),  Alexa  Fluor  647–conjugated  anti-CD34 
(RAM-34; eBioscience), and an allophycocyanin (APC)-Cy7–conjugated 
or a biotinylated anti–lineage marker antibody cocktail (anti-CD4, -CD8, 
-CD11b, -CD45R, -CD127, –Gr-1, and -TER119 antibodies; eBiosci-
ence). The biotinylated anti–lineage marker cocktail was developed using 
streptavidin-conjugated APC-Cy7.
For  staining  of  PE-conjugated  antibodies,  as  when  PE-conjugated 
anti-CD38 (90) or PE-conjugated anti-CD150 (TC15-12F12.2; BioLeg-
end) was used, CD34KSL cells were identified by FITC-conjugated anti-
CD34  (RAM-34),  PE-Cy7–conjugated  anti–Sca-1,  APC-conjugated 
anti–c-Kit, and APC-Cy7–conjugated or biotinylated anti–lineage marker 
antibodies. The biotinylated antibodies of interest were developed with 
streptavidin-PE. PE-conjugated anti–rabbit IgG was used for visualization 
of unconjugated antibody. To test anti-CD4, -CD8, -CD11b, -CD45R, 1182 Heterogeneity and hierarchy of HSCs | Morita et al.
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